Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Remdesivir is a nucleoside analog that inhibits the SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and is used as a drug to treat COVID19 patients. Here, the authors provide insights into the mechanism of remdesivir-induced RdRp stalling by determining the cryo-EM structures of SARS-CoV-2 RdRp with...
Enregistré dans:
Auteurs principaux: | Goran Kokic, Hauke S. Hillen, Dimitry Tegunov, Christian Dienemann, Florian Seitz, Jana Schmitzova, Lucas Farnung, Aaron Siewert, Claudia Höbartner, Patrick Cramer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8b3f1fceaaca4cfa95f1314132c6731b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The structure of a dimeric form of SARS-CoV-2 polymerase
par: Florian A. Jochheim, et autres
Publié: (2021) -
Structural basis of TFIIH activation for nucleotide excision repair
par: Goran Kokic, et autres
Publié: (2019) -
Structure of transcribing RNA polymerase II-nucleosome complex
par: Lucas Farnung, et autres
Publié: (2018) -
Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides
par: Bing Wang, et autres
Publié: (2021) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
par: Maria L. Agostini, et autres
Publié: (2018)